questionsmedicales.fr
Phénomènes microbiologiques
Phénomènes physiologiques viraux
Réplication virale
Activation virale
Activation virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Activation virale : Questions médicales les plus fréquentes",
"headline": "Activation virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Activation virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Activation virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Réplication virale",
"url": "https://questionsmedicales.fr/mesh/D014779",
"about": {
"@type": "MedicalCondition",
"name": "Réplication virale",
"code": {
"@type": "MedicalCode",
"code": "D014779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06.920.925"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Activation virale",
"alternateName": "Virus Activation",
"code": {
"@type": "MedicalCode",
"code": "D014775",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Ryosuke Morimoto",
"url": "https://questionsmedicales.fr/author/Ryosuke%20Morimoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan."
}
},
{
"@type": "Person",
"name": "Yuji Isegawa",
"url": "https://questionsmedicales.fr/author/Yuji%20Isegawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan."
}
},
{
"@type": "Person",
"name": "Janejira Jaratsittisin",
"url": "https://questionsmedicales.fr/author/Janejira%20Jaratsittisin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Characteristics and survival of patients with cancer with intended off-label use-a cohort study.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35613810",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2021-060453"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders.",
"datePublished": "2023-06-16",
"url": "https://questionsmedicales.fr/article/37331618",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ad.2023.06.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Off-Label Use of a Tensioned Proximal Humerus Plate for Tibiotalar Fusion: A Case Report.",
"datePublished": "2022-11-18",
"url": "https://questionsmedicales.fr/article/36862106",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2106/JBJS.CC.22.00576"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders.",
"datePublished": "2023-08-03",
"url": "https://questionsmedicales.fr/article/37543140",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ad.2023.08.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety and user experience with off-label use of a flash glucose monitor (FreeStyle Libre",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36595216",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/jpem-2022-0452"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008827"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques viraux",
"item": "https://questionsmedicales.fr/mesh/D018406"
},
{
"@type": "ListItem",
"position": 4,
"name": "Réplication virale",
"item": "https://questionsmedicales.fr/mesh/D014779"
},
{
"@type": "ListItem",
"position": 5,
"name": "Activation virale",
"item": "https://questionsmedicales.fr/mesh/D014775"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Activation virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Activation virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Activation virale",
"description": "Comment diagnostiquer une activation virale ?\nQuels tests sont utilisés pour détecter les virus activés ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on détecter un virus inactif ?\nLes biopsies sont-elles utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Off-Label+Use&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Activation virale",
"description": "Quels sont les symptômes d'une activation virale ?\nLes symptômes varient-ils selon le virus ?\nL'activation virale cause-t-elle des complications ?\nLes symptômes apparaissent-ils rapidement ?\nPeut-on avoir des symptômes sans activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Off-Label+Use&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Activation virale",
"description": "Comment prévenir l'activation virale ?\nLe lavage des mains aide-t-il à prévenir les infections ?\nLes masques protègent-ils contre les virus ?\nLes voyages augmentent-ils le risque d'activation virale ?\nLes comportements à risque augmentent-ils l'activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Off-Label+Use&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Activation virale",
"description": "Quels traitements existent pour l'activation virale ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nLes vaccins aident-ils à prévenir l'activation virale ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Off-Label+Use&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Activation virale",
"description": "Quelles sont les complications possibles d'une activation virale ?\nL'activation virale peut-elle entraîner des maladies chroniques ?\nLes complications sont-elles prévisibles ?\nLes enfants sont-ils plus à risque de complications ?\nComment gérer les complications d'une activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Off-Label+Use&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Activation virale",
"description": "Quels sont les facteurs de risque d'activation virale ?\nL'âge influence-t-il le risque d'activation virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie affecte-t-il le risque d'activation virale ?\nLe stress psychologique influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Off-Label+Use&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des cultures virales peuvent confirmer l'activation."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les virus activés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les sérologies sont couramment utilisés pour détecter les virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent souvent vers une activation virale."
}
},
{
"@type": "Question",
"name": "Peut-on détecter un virus inactif ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les tests ne détectent que les virus actifs ou en phase de réplication."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à identifier des infections virales localisées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une activation virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques et variés."
}
},
{
"@type": "Question",
"name": "L'activation virale cause-t-elle des complications ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications graves comme des pneumonies ou des encéphalites."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent apparaître rapidement ou après une période d'incubation prolongée."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans activation virale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres maladies peuvent provoquer des symptômes similaires sans activation virale."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation virale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des contacts sont essentiels."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir les infections ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon lavage des mains réduit le risque de transmission virale."
}
},
{
"@type": "Question",
"name": "Les masques protègent-ils contre les virus ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques peuvent réduire la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'activation virale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les comportements à risque augmentent-ils l'activation virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements comme le partage d'aiguilles augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'activation virale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunomodulateurs et les soins de soutien sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins aident-ils à prévenir l'activation virale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent prévenir certaines infections virales et leur activation."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale, réduisant ainsi la charge virale dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une activation virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, l'encéphalite ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'activation virale peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent provoquer des maladies chroniques comme l'hépatite."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé de l'hôte."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables à certaines complications virales."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une activation virale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements appropriés sont essentiels pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'activation virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le stress et les voyages fréquents augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'activation virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et les jeunes enfants sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou le VIH augmentent le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'activation virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
}
]
}
]
}
To describe the characteristics and the survival of patients with cancer with intended off-label use (OLU) cancer treatment and reimbursement request....
Cohort study using medical record data....
Three major cancer centres in Switzerland....
519 patients with cancer and a reimbursement request for OLU between January 2015 and July 2018....
Characteristics of patients with cancer with and without access to intended OLU. Characteristics included the Glasgow prognostic score (GPS) which includes C reactive protein and albumin and discrimin...
OLU was intended for 519 (17%) of 3046 patients with cancer, as first-line treatment in 51% (n=264) and second-line in 31% (n=162). Of the 519 patients, 63% (n=328) were male, 63% (n=329) had solid ca...
Contrary to the common assumption, OLU in oncology is typically not primarily intended for patients with exhausted treatment options. Patient characteristics largely differ between patients with and w...
JAK inhibitors target specific inflammatory cytokines involved in various inflammatory diseases. Four molecules have been approved for dermatological use: upadacitinib, baricitinib, abrocitinib and to...
A 70-year-old man presented with a left pilon fracture after a 10-foot fall from a ladder. The severe amount of comminution, joint destruction, and impaction from this injury eventually resulted in a ...
We do not endorse the off-label use of a tensioned proximal humerus plate for all tibiotalar fusions; however, we do believe that this is a useful technique in certain situations with large zones of d...
JAK inhibitors target specific inflammatory cytokines involved in various inflammatory diseases. Four molecules have been approved for dermatological use: upadacitinib, baricitinib, abrocitinib and to...
FreeStyle Libre 1 (FGM) has been approved by the FDA for children older than 4 years. It enables noninvasive glucose monitoring without the need for finger pricking. Parents of very young children oft...
This was an ambi-directional cohort study. We recruited parents of very young children with type 1 diabetes mellitus (T1DM) who were less than 5 years old when they started using FGM at the King Saud ...
We included 31 children with mean age of the children when they started using FGM was 3.88 ± 1.10 years (range, 1.46-5.4 years), and the mean sensor use was 2.3 ± 1.3 years. During the use of the devi...
The safety profile of FGM used for very young children with T1DM is the same for older children, which leads to improved metabolic control and sleep quality of both the parent and the child....
As an adjuvant drug, alprostadil lipid microsphere injection (Lipo-PGE...
To examine the current prevalence and cost of paediatric off-label drug prescriptions in Gansu, China, and the potential influencing factors....
The prevalence of off-label prescriptions in paediatrics was evaluated according to the National Medical Products Administration drug instructions in the China Pharmaceutical Reference (China Pharmace...
A multicentre cross-sectional study of outpatient paediatric prescriptions in 196 secondary and tertiary hospitals in Gansu Province, China, in March and September 2020....
We retrieved 104 029 paediatric prescriptions, of which 39 480 (38.0%) contained off-label use. The most common diseases treated by off-label drugs were respiratory system diseases (n=15 831, 40.1%). ...
Off-label drug use is widespread in paediatric practice in China. Three-quarters of the prescriptions may potentially include inappropriate medication use, resulting in a daily economic burden of abou...
Until recently, few therapeutic options, other than symptomatic treatment, were available for patients with primary progressive multiple sclerosis (PPMS). Ocrelizumab is the only approved treatment in...
To evaluate published data concerning the efficacy of these five treatments frequently used as off-label disease-modifying therapies....
We reviewed and summarized the studies published in Pubmed since the inception of the database....
Evidence from randomized controlled trials is lacking to support the use of these treatments as disease-modifying therapies in PPMS....
The literature lacks dedicated studies to support the off-label use of these disease-modifying therapies in PPMS. However, some limited data are available in the literature suggesting that the use of ...
Using commercially available automated insulin delivery (AID) systems for treating type 1 diabetes during pregnancy remains controversial. This retrospective study assessed six pregnant women with typ...
Off-label use is frequently practiced in hip revision arthroplasty, as there may be indications for the application of implants for purposes outside the one the manufacturers intended (i.e. large bone...